LVZPFLivzon Pharmaceutical Group Inc.$ --
Livzon Pharmaceutical Group Inc.
LVZPF
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
wallet
Earnings SummaryUpdated: 09/30/2025FY2025 Q3
Revenue
2,842M CNY
YoY +1.5%
Operating Income
599M CNY
YoY -14.9%
Net Income
473M CNY
YoY -5.8%
EPS
0.54CNY
YoY -1.8%
Revenue
CNY9.1B
Actual
+CNY70.5M (+0.8%)
Net Income
CNY1.8B
Actual
+CNY81M (+4.8%)
Surprise History
Actual RevenueAnalyst Estimate
FY2019MISS
Actual:CNY9.4B
Est:CNY9.6B
FY2019MISS
FY2020MISS
Actual:CNY10.5B
Est:CNY10.6B
FY2020MISS
FY2021BEAT
Actual:CNY12.1B
Est:CNY11.8B
FY2021BEAT
FY2022MISS
Actual:CNY12.6B
Est:CNY12.7B
FY2022MISS
FY2023MISS
Actual:CNY12.4B
Est:CNY12.9B
FY2023MISS
FY2024BEAT
Actual:CNY11.8B
Est:CNY11.8B
FY2024BEAT